Cedars-Sinai Partners with Redesign Health to Launch Digital Innovation Platform

What You Should Know: 

– Cedars-Sinai today announced the launch of a new Digital Innovation Platform, a significant initiative aimed at developing transformative solutions for some of the most critical issues facing the U.S. healthcare system. 

– The platform will harness Cedars-Sinai’s renowned clinical expertise, extensive infrastructure, research capabilities, and vast data resources to build innovative healthcare companies in collaboration with its staff, investors, and the prominent venture-builder Redesign Health.

Fostering Digital Health Innovation

The initiative arrives as the U.S. healthcare system continues to grapple with substantial obstacles, including escalating costs, persistent workforce shortages, operational inefficiencies, and the increasing complexity of patient care. Cedars-Sinai’s Digital Innovation Platform is designed to directly address these hurdles by fostering the development and scaling of solutions that are not only clinically effective but also operationally scalable and financially sustainable.

Redesign Health Strategic Partnership to Build and Scale Innovation

A key component of this new platform is the collaboration with Redesign Health, a venture builder with a strong track record, having successfully launched more than 60 healthcare companies over the past seven years. Cedars-Sinai will leverage Redesign Health’s scalable innovation model to create a sustainable innovation center by integrating the rich resources and extensive network of an academic healthcare system.

The Digital Innovation Platform will actively source external talent—including healthcare business strategists, engineers, and data scientists—who will work alongside Cedars-Sinai’s internal clinical experts. Together, they will utilize emerging technologies to develop and scale new digital health solutions targeting critical needs such as personalized medicine, improved access to specialty care, hospital workflow optimization, enhanced clinical decision support, and increased coordination among patients, providers, and payers.

Fostering Entrepreneurship and Real-World Validation

Cedars-Sinai clinicians, researchers, and staff members will be integral to the platform. A new, structured entrepreneurship program will encourage them to identify everyday challenges that could be solved through digital innovation, fostering a culture of entrepreneurship and providing mentorship to recognize and develop these opportunities. The companies formed will, in turn, benefit immensely from the clinical expertise of Cedars-Sinai’s personnel.

Experienced founders will be recruited to lead these new ventures, with Cedars-Sinai serving as their first large-scale customer to validate the solutions. These founders will gain access to an integrated data platform currently under development by Cedars-Sinai, which will utilize deidentified, secure, and synthetic data—artificial data designed to mimic real-world patterns. This enterprise tool will offer access to large, diverse datasets, providing crucial infrastructure and insights to facilitate the use of AI and other emerging technologies in solution design and support company growth at every stage.

“Cedars-Sinai is uniquely positioned to develop new and innovative ways to fix some of the most pressing problems in healthcare today, thanks to our focus on translational medicine and our ability to bring together leading-edge clinical care, research, AI and strategic industry relationships to benefit our patients,” said Peter L. Slavin, MD, president and CEO of Cedars-Sinai and the David and Meredith Kaplan Presidential Chair. “This bold approach and unique ecosystem will allow us to address healthcare challenges on a deeper level and move faster by collaborating with key partners to develop innovations that have been shown to work in real-world, clinical environments.”